A new series of isatin–isoxazoline hybrids was prepared through 1,3-dipolar cycloaddition reactions involving arylnitrile oxides and 1-(undec-10-en-1-yl)indoline-2,3-dione. The synthesized compounds were obtained in satisfactory yields and characterized by nuclear magnetic resonance spectroscopy, while the molecular structures of two isatin–isoxazoline derivatives were unambiguously established by single-crystal X-ray diffraction. The potential of molecular docking against cyclin-dependent kinase 2 (CDK2; PDB ID: 7RWF) was studied. In addition, SwissADME predictions suggested favorable drug-likeness and pharmacokinetic properties for all compounds, including compliance with Lipinski’s rule of five, high predicted gastrointestinal absorption, and satisfactory bioavailability scores.
No takes yet. Share an insight, caveat, or question.
Rharmili et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: